These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 511374

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Regular hemoperfusion in regular dialysis treatment. A long-term study.
    Stefoni S, Colì L, Feliciangeli G, Baldrati L, Bonomini V.
    Int J Artif Organs; 1980 Nov; 3(6):348-53. PubMed ID: 7461873
    [Abstract] [Full Text] [Related]

  • 3. Solute, amino acid, and hormone changes with coated charcoal hemoperfusion in uremia.
    Winchester JF, Ratcliffe JG, Carlyle E, Kennedy AC.
    Kidney Int; 1978 Jul; 14(1):74-81. PubMed ID: 682427
    [Abstract] [Full Text] [Related]

  • 4. Use of combined hemodialysis/hemoperfusion in chronic uremia.
    Stefoni S, Feliciangeli G, Colì L, Prandini R, Bonomini V.
    Contrib Nephrol; 1982 Jul; 29():123-32. PubMed ID: 6804167
    [Abstract] [Full Text] [Related]

  • 5. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.
    Splendiani G, Albano V, Tancredi M, Daniele M, Pignatelli F.
    Biomater Artif Cells Artif Organs; 1987 Jul; 15(1):175-81. PubMed ID: 3449135
    [Abstract] [Full Text] [Related]

  • 6. Hemoperfusion in chronic uremia.
    Stefoni S, Feliciangeli G, Cianciolo G, De Sanctis LB, Giardino R, Spighi M.
    Boll Soc Ital Biol Sper; 1993 Nov; 69(11):675-82. PubMed ID: 8060597
    [Abstract] [Full Text] [Related]

  • 7. Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency.
    Weiss LG, Danielson BG, Fellström B, Wikström B.
    Nephron; 1989 Nov; 51(3):325-9. PubMed ID: 2918944
    [Abstract] [Full Text] [Related]

  • 8. Long-term clinical assessment of combined ACAC hemoperfusion-ultrafiltration in uremia.
    Chang TM, Chirito E, Barre P, Cole C, Lister C, Resurreccion E.
    Artif Organs; 1979 May; 3(2):127-31. PubMed ID: 533395
    [Abstract] [Full Text] [Related]

  • 9. Hemoperfusion in reduced-time programmes for chronic uremia. Long-term results.
    Stefoni S, Colì L, Feliciangeli G, Scolari MP, Bonomini V.
    Int J Artif Organs; 1986 Sep; 9(5):297-300. PubMed ID: 3781660
    [Abstract] [Full Text] [Related]

  • 10. Present status of hemoperfusion/hemodialysis in Italy.
    Bonomini V, Stefoni S, Feliciangeli G, Colì L, Scolari MP, Prandini R, Casciani CU, Taccone Gallucci M, Albertazzi A, Mioli V.
    Appl Biochem Biotechnol; 1984 Sep; 10():157-66. PubMed ID: 6395806
    [Abstract] [Full Text] [Related]

  • 11. Shortened treatment time by combined hemodialysis and hemoperfusion.
    Bonomini V, Stefoni S, Feliciangeli G, Colì L, Scolari MP, Orsi C, Nanni Costa A, Prandini R, Galanti S.
    Contrib Nephrol; 1985 Sep; 44():57-64. PubMed ID: 3987293
    [No Abstract] [Full Text] [Related]

  • 12. Failure of platelet markers to evaluate membrane biocompatibility during a combined hemodialysis-hemoperfusion treatment.
    Buccianti G, Giaretto S, Pogliani EM, Lorenz M, Valenti G, Bianchi ML, Cresseri D.
    Artif Organs; 1987 Oct; 11(5):416-20. PubMed ID: 2961320
    [Abstract] [Full Text] [Related]

  • 13. Combined hemoperfusion/hemodialysis in the treatment of uremic patients with vascular access problems: case reports.
    Espinosa-Meléndez E, Bourgouin PA, Chang TM.
    Int J Artif Organs; 1986 Sep; 9(5):309-12. PubMed ID: 3781661
    [No Abstract] [Full Text] [Related]

  • 14. Sorbent membrane dialysis in uremia.
    Randerson DH, Gurland HJ, Schmidt B, Farrell PC, Hone PW, Stokoe C, Zuber A, Blogg A, Fateh-Moghadam A, Marschner I, Köpcke W.
    Contrib Nephrol; 1982 Sep; 29():53-64. PubMed ID: 7075216
    [Abstract] [Full Text] [Related]

  • 15. Biocompatibility of charcoal hemoperfusion. Effects of long-term treatment on lymphocyte characteristics and function.
    Stefoni S, Nanni Costa A, D'Arcangelo GL, Biavati M, Iannelli S, Bonomini V.
    Int J Artif Organs; 1986 Sep; 9(5):301-4. PubMed ID: 3491055
    [Abstract] [Full Text] [Related]

  • 16. Hemoperfusion results in uremia.
    Gelfand MC, Winchester JF.
    Clin Nephrol; 1979 Feb; 11(2):107-10. PubMed ID: 378488
    [No Abstract] [Full Text] [Related]

  • 17. Hemoperfusion based on artificial cells for aluminium and iron removal, immunosorption, fulminant hepatic failure, uremia, poisoning and metabolic assists.
    Chang TM.
    Int J Artif Organs; 1986 Sep; 9(5):285-8. PubMed ID: 3781657
    [Abstract] [Full Text] [Related]

  • 18. Hemoperfusion for uremia: past, present, and future.
    Winchester JF, Ash SR.
    Kidney Int Suppl; 1985 Dec; 17():S127-30. PubMed ID: 3867782
    [No Abstract] [Full Text] [Related]

  • 19. The best coating material for hemoperfusion: comparation of cellulose nitrate with cellulose acetate and derivatives.
    Pişkin E, Cakmakli C, Ozdural AR.
    Int J Artif Organs; 1981 Mar; 4(2):86-8. PubMed ID: 7275339
    [Abstract] [Full Text] [Related]

  • 20. Hemoperfusion in 1981.
    Chang TM.
    Contrib Nephrol; 1982 Mar; 29():11-22. PubMed ID: 7042197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.